144.9, 140.6, 137.9, 136.9, 133.2, 128.3, 126.1, 126.0, 125.2, 124.4, 121.6, 119.8, 118.8, 108.1, 106.2.
ESI-MS(-)
Fluorescence Assay for MMP-2 and MMP-9. The assay was carried out in white NUNC* 96-well opaque round-bottomed plates as previously described. 4 For the assay, each well contained a total volume of 90 µL including buffer (50 mM HEPES, 10 mM CaCl 2 , 0.05% Brij-35, pH 7.5), human recombinant MMP (ENZO Life Sciences; 1.16 U MMP-2 and 0.9 U MMP-9), and compound 7 (50 µM final concentration). After a 30 min incubation period at 37 °C, the reaction was initiated by the addition of 10 µL of the fluorogenic MMP substrate (4 µM final concentration, Mca-Pro-Leu-Gly-LeuDpa-Ala-Arg-NH 2 ·AcOH, ENZO Life Sciences). Fluorescence measurements were recorded using a Bio-Tek Flx 800 fluorescence plate reader every minute for 20 min at excitation and emission wavelengths of 320 and 400 nm, respectively. The rate of fluorescence increase was compared for samples and negative controls (no inhibitor, arbitrarily set as 100% activity). CGS 27023A, a broad spectrum MMP inhibitor, was used as a positive control (IC 50 value ~20 and 8 nM of MMP-2 and MMP-9, respectively; MacPherson et al. J. Med. Chem., 1997, 40, 2525-2532).
Mushroom Tyrosinase (TY).
The assay was carried out as previously described (Liu, J.; Yi, W.; Wan, Y.; Ma, L.; Song, H. Bioorg. Med. Chem. 2008, 16, 1096-1102) . The assay was performed in black 96-well clear flat-bottomed plates with each well containing a total volume of 100 µL. This included buffer (5 mM phosphate, pH 6.8), mushroom TY (30 U, Sigma-Aldrich), inhibitor (50 µM), and Ldopamine (0.5 mM, Sigma-Aldrich). Mushroom TY and inhibitor were preincubated in the buffer solution at room temperature for 10 min. A background absorbance reading at 475 nm was recorded using a Bio-Tek ELx 808 colorimetric plate reader. L-Dopamine was added to initiate the reaction, which was allowed to proceed for 10 min before a second absorbance reading at 475 nm was taken. After subtracting the background absorbance, the remaining absorbance of the negative controls (no inhibitor) was arbitrarily set as 100% activity. The ratio of absorbance between inhibitor and control wells was defined as percent TY activity.
Human Carbonic Anhydrase II (hCAII)
. hCAII activity was measured in 50 mM Tris (pH 8) using an esterase activity assay with 4-nitrophenyl acetate as the substrate. Conversion of 4-nitrophenyl acetate to 4-nitrophenol by hCAII is observed as an increase in absorbance at 405 nm, which was read on a BioTek ELx808 plate reader. Protein (100 nM, final concentration, expressed as previously described in Monnard F.W.; Heinisch, T.; Nogueira, E.S.; Schirmer, T; Ward, T.R. Chem. Commun., 2011, 47, 8238-8240) was incubated with inhibitor (50 µM) for 10 min at room temperature followed by addition of substrate (in DMSO, 500 µM final concentration). The total well volume (clear, flat-bottom, 96-well plates) was 100 µL and contained 5% DMSO. Initial linear rates were compared to both negative (inhibitor-free) and positive (100% inhibition with 50 µM) 5 controls in order to determine percent inhibition. Acetazolamide, a clinically used hCAII inhibitor, was used as a positive control (IC 50 value ~12 nM; Krishnamurthyet al. Chem Rev. 2008, 108, 946-1051) . Figure S5 . Metalloenzyme specificity of 2 versus 7a (50 µM). Positive control compound for MMP-2 and MMP-9 was CGS 27023A (IC 50 value ~20 and 8 nM of MMP-2 and MMP-9, respectively), for hCAII was acetazolamide (IC 50 value ~12 nM), and for tyrosinase was tropolone (IC 50 value ~400 nM, 3).
D. Bacterial Viability and Swarming
Overnight cultures of P. aeruginosa strain PA14, prepared in Tryptic soy broth (TSB) at 37 °C (250 rpm), were diluted with fresh media (1:1,000) and treated with varying concentrations of 7a. Bacterial viability was then determined by measuring the OD 600 of the culture in the presence of compound. All concentrations were analyzed in triplicate and the average of the results with 1:1000 dilution are shown in Figure S3 . Toxicity was observed at concentrations >25 µM. Figure S6 . Viability of PA14 in the presence of 7a.
P. aeruginosa Swarming Assay.
A swarming motility assay using P. aeruginosa strain PA14 was executed as previously described. 6 Overnight cultures of PA14 strain, prepared in Tryptic soy broth (TSB) at 37 °C (250 rpm), were washed (3×) with phosphate-buffered saline buffer (pH 7.4). The washed culture was then diluted with the same buffer to an OD 600 of ~3.0. Swarm agar medium was a modified M9 agar medium and contained: 20 mM NH 4 Cl, 12 mM Na 2 HPO 4 , 22 mM KH 2 PO 4 , 8.6 mM NaCl, 1 mM MgSO 4 , 1 mM CaCl 2 •2 H 2 O, 11 mM dextrose, 0.5% casamino acids (Difco) and Bacto-agar (Difco). The medium was autoclaved, and upon cooling was diluted with filter-sterilized MgSO 4 and CaCl 2 2H 2 O. ~20 mL of swarm agar medium containing compound 7a (25 µM) was poured into 100×25 mm Petri dishes housed in a laminar flow cabinet and dried for 1 h. 5 µL of the bacterial culture (OD 600 of ~3.0) was spotted onto each plate followed by incubation at 30 °C for 18 h. Stability of Compound 10. The stability of compound 10 was assessed in Tryptic soy broth (TSB). A sample containing 50 µM compound was incubated at 37 °C for 24 h to mirror swarming conditions and analyzed using LC-MS to monitor for hydrolysis. Samples were analyzed at 6 h and 24 h ( Figure  S8 ). After 24 h, complete hydrolysis of compound 10 to 7a was observed. Figure S8 . ESI-MS examining the stability of compound 10 in Tryptic soy broth (TSB). Samples were analyzed at 6 h (left) and 24 h (right). After 24 h, complete hydrolysis of compound 10 to 7a was observed (right). 
